Athenex (ATNX) PT Lowered to $13 at Laidlaw, Following FDA CRL, Earnings
Tweet Send to a Friend
Laidlaw analyst Yale Jen lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE